Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Larotaxel + Trastuzumab in HER2+ MBC
NCT00386685Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jul 2006
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 2, open-label, single-arm trial of larotaxel in breast cancer, sponsored by Sanofi. Primary endpoint: Best Overall Response Rate. Started Jul 2006; status: completed.
02
Drugs
larotaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00386685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00386685.